Cerebellum-based Imaging Neural Markers for Antipsychotic Response

Clinical trial NCT07483294 · RECRUITING

Trial details

NCT number: NCT07483294
Sponsor: Northwell Health
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Psychosis; Acute

Start date: 2025-11-01
Primary completion: 2029-12-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.